DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Roswell Park Cancer Institute
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Massachusetts General Hospital
Massachusetts General Hospital
M.D. Anderson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Heinrich-Heine University, Duesseldorf
M.D. Anderson Cancer Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Universitätsklinikum Hamburg-Eppendorf
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of California, Davis
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Northwestern University
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Fox Chase Cancer Center
Groupe Francophone des Myelodysplasies
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Heinrich-Heine University, Duesseldorf
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
Fred Hutchinson Cancer Center